Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.
Sesame Therapeutics has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
Sesame Therapeutics's investors include Qiming Venture Partners.
Sesame Therapeutics is headquartered in Plymouth, United States.
Sesame Therapeutics is a healthcare company that provides precision oncology medicines with therapeutic windows.
Sesame Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sesame Therapeutics — Funding & Investors." VCBacked, July 3, 2025, https://www.vcbacked.co/company/sesame-therapeutics. Accessed July 20, 2026.
VCBacked. (2025). Sesame Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/sesame-therapeutics
{{cite web |title=Sesame Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sesame-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated